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amount of miles that a person drives.6 8 When modern
methods were used to examine the visual field of
10 000 drivers, severe binocular field loss was
associated with a 100% increase in crash rates.9 Unfor›
tunately, these authors did not define “severe binocular
field loss.” This association between peripheral field
loss and increased crash frequency has been confirmed
by some investigators5 but not others.6 7
It is difficult to establish the relation between visual
impairment and crash rates because visually impaired
drivers tend to restrict their driving habits and change
their behaviour to compensate for their visual loss.8 10 11
Crashes are fortunately rare events with multiple
causes, and the effects of a driver’s visual impairment
are dwarfed by other factors such as the annual
mileage driven, the driver’s age, inattention, intoxica›
tion, and speeding. Furthermore, it is unsurprising that
it is difficult to predict crash rates from measures of
static visual acuity and the peripheral visual field since
these indices do not reflect the visual, perceptual, and
cognitive complexity of the driving task. There is some
evidence that relicensing policies based on measure›
ments of static acuity and visual field reduce accidents
on the road.12 However, many drivers who fail these
requirements are at no greater risk of being involved in
a crash than a road user who is not visually impaired.
Although the relationship between reduced acuity,
visual field loss, and crash rates is weak, relaxing the
requirements further cannot be justified because it
would lead to a small increase in crash frequency. As
the population ages so the incidence of visual
impairment will increase, and with it the number of
drivers who are unfairly debarred.4–7
The solution to this problem lies in the use of cog›
nitive and perceptual tests that are better predictors of
crash involvement. These may take the form of more
sophisticated tests of vision,5 7 driving simulator assess›
ments,12 driving tests on the road,13 or other objective
measures of performance.14 In a retrospective study of
an older population a test of central processing time,
divided attention, and peripheral discrimination
abilities within the central part of the visual field corre›
lated highly with crash frequency over the preceding
five years.5 A further prospective study shows that over
a three year follow up a poor performance in this test
was associated with a doubling in the relative risk of
crash involvement.7 No association was found between
visual acuity or field measurements and crash rates for
the same population.
In the short term the low cost, widespread
acceptance, and availability of static visual acuity and
perimetric measures justifies their use. But other tests
should be developed to help determine the driving
ability of people who do not meet the current
standards and, when appropriate, allow them to retain
their licences.
Meanwhile the Driver and Vehicle Licensing
Authority in the United Kingdom should monitor and
audit the results of the current visual requirements. It
should collect data to confirm that there is at least
some benefit for society from the devastating effect that
removal of a driving licence can have upon a visually
impaired individual.
William Westlake visiting research fellow
McCusker Glaucoma Unit, The Lions Eye Institute, 2 Verdun Street,
Nedlands 6009,Western Australia
1 Drasdo N, Haggerty CM. A comparison of the British number plate and
Snellen vision tests for car drivers Ophthalmic Physiol Opt 1981;1:39›54.
2 Currie Z, Bhan A, Pepper I. Reliability of Snellen charts for testing visual
acuity for driving: prospective study and postal questionnaire. BMJ
2000;321:990›2.
3 Burg A. Vision and driving: a report on research. Human Factors
1971;13:79›87.
4 Hills B, Burg A. A reanalysis of California driver vision data: general findings.
Crowthorne, Berkshire: Transport and Road Research Laboratories,
1977.
5 Ball K, Owsley C, Sloane M, Roenker D, Bruni J. Visual attention
problems as a predictor of vehicle crashes in older drivers. Invest Ophthal›
mol Vis Sci 1993;34:3110›23.
6 Ivers R, Mitchell P, Cumming R . Sensory impairment and driving: the
Blue Mountains eye study. Am J Public Health 1999;89:85›7.
7 Owsley C, Ball K, McGwin G, Sloane M, Roenker D, White M, et al. Visual
processing and risk of crash amongst older adults. JAMA
1998,279:1083›8.
8 Council F, Allen J. A study of visual fields of North Carolina drivers and their
relationships to accidents. Chapel Hill, NC: Highway Safety Research
Centre University of North Carolina, 1974.
9 Johnson C, Keltner J. Incidence of field loss in 20,000 eyes and its
relationship to driving performance. Arch Ophthalmol 1983;101:371›5.
10 Shinar D, Schieber F. Visual requirements for safety and mobility of older
drivers. Human Factors 1991;33:507›19.
11 Szlyk JP, Seiple W, Viana M. Relative effects of age and compromised
vision on driving performance. Human Factors 1995;37:430›6.
12 Shipp MD. Potential human and economic cost›savings attributable to
vision testing policies for driver license renewal,1989›1991. Optom Vis Sci
1998;75:103›18.
13 Odenheimer GL, Beaudot M, Jette AM, Albert MS, Grande L, Minaker
KL. Performance›based driving evaluation of the elderly driver: safety
reliability, and validity. J Gerontol 1994;49:M153›9.
14 Irving A, Jones W. Methods for testing impairment of driving due to
drugs. Eur J Clin Pharmacol 1992;43:61›6.
Headaches after diagnostic dural punctures
Smaller, atraumatic needles and protocols for early treatment should reduce morbidity
In a dural puncture a needle is passed through thedura mater into the cerebrospinal fluid within thespinal canal. It is commonly performed and is
indicated for diagnostic lumbar puncture, spinal
anaesthesia, myelography, and intrathecal chemo›
therapy. The most common adverse event after the
procedure is a headache. This occurs in about a third
of patients after diagnostic lumbar puncture in an
ambulatory setting with a 20 or 22 gauge standard
Quincke bevel spinal needle.1
The aetiology of the headache from the dural
puncture is most likely related to the hole left in the
dura after the needle has been withdrawn. This allows
the cerebrospinal fluid to leak out of the subarachnoid
space, which depletes the “cushion” of fluid supporting
the brain and its sensitive meningovascular covering,
resulting in gravitational traction and the classic head›
ache, which is made worse when the patient is upright
and relieved on lying down.2 The headache, the onset
of which is often delayed for 24 to 48 hours, usually
lasts for one or two days and is frequently severe
enough to immobilise the patient.3 Rarely, it can persist
for a year or more and if untreated can predispose to
subdural haematomas.4 5 In one survey of 14 people
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with subdural haematomas after dural punctures four
patients died.6 The risk of developing a headache from
a dural puncture is greater in patients who are
younger, female, and pregnant.3
The leakage of cerebrospinal fluid from the
subarachnoid space, and consequent incidence and
severity of headache, can be reduced by decreasing the
size of the hole in the dura.7 This can be done by using
smaller needle gauges, an atraumatic design of needle
tip as opposed to the standard version, orienting the
bevel of the needle parallel to the longitudinal axis of
the spinal cord, approaching the dura tangentially
(paramedial versus midline approach), making fewer
attempts at dural puncture, and withdrawing atrau›
matic needles with the stylet in situ.2 7›10
Atraumatic needle tips leave a smaller hole in the
dura than Quincke tips—it is thought they cause
temporary separation rather than cutting of the elastic
fibres, which then recoil after removal of the needle.8
The term “atraumatic” may be misleading as a recent
study shows that the dural defect after puncture by
these needles was actually more traumatic, with tearing
and severe disruption of the collagen fibres, than that
found with Quincke tips.11 The authors hypothesised
that the inflammatory reaction set up by this trauma
could act as a plug, limiting the leakage of cerebro›
spinal fluid and so reducing the incidence of headache.
In this week’s issue of the BMJ Thomas and
colleagues (p 986) show a decrease from 54% to 29%
in the incidence of moderate to severe headache after
dural puncture at one week after diagnostic lumbar
puncture when using 20 gauge atraumatic needles
rather than Quincke spinal needles.12 This reduction is
admirable, but there is a world of difference between
this and spinal anaesthesia, where the incidence has
been reduced to 7% and 1% with 22 gauge and 25
gauge atraumatic needles respectively.13 Follow up
routines after spinal anaesthesia, particularly for
obstetric and ambulatory surgery, are well established,
and an incidence of greater than 1% would lead to
major debate about restricting the procedure.
Anaesthetists frequently perform lumbar punctures,
and trainees quickly become competent at using the
smaller gauge needles. Epidural blood patching (the
placement of 15›20 ml of autologous blood into the
epidural space near the dural puncture site) to treat
severe headaches after dural punctures is also widely
practised by anaesthetists. Physicians in training could
easily be taught these procedures and perhaps would
benefit from some exposure to the practice of spinal
anaesthesia.
It is claimed that diagnostic dural puncture cannot
be performed with a needle smaller than 22 gauge
because of the need to collect adequate volumes of
cerebrospinal fluid and accurately measure intrathecal
pressure.14 However, the needle gauge, and consequent
incidence of headache, could be reduced if two
fundamental changes in practice were considered.
Firstly, a sample of fluid can be obtained easily by gentle
aseptic aspiration using a syringe, in which 2 ml can be
collected in less than a minute via a 24 gauge needle.15
Secondly, accurate and reliable pressure measurements
can be made with 25 gauge spinal needles using an
aseptic transducer system.15 16 These changes require
the input of a clinician competent in performing
lumbar punctures.
Prevention is always better than cure, and using the
smallest gauge of atraumatic needle possible for a pro›
cedure would bring about the biggest reduction in the
incidence of headache after dural puncture. This is well
established in the anaesthetic literature and is now also
emerging for diagnostic dural puncture. A systematic
review from the Cochrane Collaboration on what nee›
dle types and techniques reduce the incidence of these
headaches is in progress, and we look forward to its
conclusions. In addition, it is important that any head›
ache after a dural puncture is diagnosed and treated
early to minimise any morbidity or mortality. This can
be done by advising patients about early symptoms
and signs and incorporating local protocols for early
treatment.17
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Correction
The management of anal warts
Two errors occurred in this editorial by Raymond Maw and
Geo von Krogh (14 October, pp 910›1). The title should
have been “The management of anogenital warts.”
Additionally, Dr Maw’s statement of competing interest was
inadvertently omitted. It should have read: RM has received
fees for speaking from 3M, which manufactures Aldara
(imiquimod). 3M and Perstorp have funded clinical trials in
his department. Perstorp manufactures pdophyllotoxin. RM
does not believe that this remuneration has influenced his
input into the editorial.
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